Previous 10 | Next 10 |
CalypsoArt/iStock via Getty Images Shares of Orphazyme (ORPH) have suddenly shot up 95% in afternoon trading on the eve of an expected FDA decision on its application for Arimoclomol for the treatment of Niemann-Pick Disease Type C ("NPC"). Trading in the stock was already briefly h...
Enochian Biosciences (ENOB) +143% on FDA acceptance of pre-IND request for potential HIV cure.MediaCo Holding (MDIA) +63%.iTeos Therapeutics (ITOS) +52%.Entasis Therapeutics Holdings (ETTX) +25%.Orphazyme A/S (ORPH) +23%.Luokung Technology (LKCO) +22%.Mereo BioPharma Group plc (MREO) +17...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back from the weekend! We’re starting off another busy week of trading right with a look at the biggest pre-market stock movers for Monday. Source: f11photo/Shutterstock.com But before that. Consider...
4 Penny Stocks To Watch This Week With Upcoming Events Penny stocks can be fickle. On the one hand, many will move with different market trends. On the other hand, they may be completely disconnected from broader sentiment. This month, we’ve seen both of these instances, with eve...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...
3 Growth Penny Stocks to Watch Right Now Finding growth penny stocks in 2021 can be challenging. With the rise of assets like Bitcoin, DogeCoin, small-caps and everything in between, this year has already become one for the books. Yesterday on June 10th, we saw the small-name biot...
Gainers: Novan (NOVN) +74%.Urban One (UONE) +39%.Iconix Brand (ICON) +28%.Aptinyx (APTX) +24%.Carver Bancorp (CARV) +22%.Vaxart (VXRT) +21%.Xinyuan Real Estate (XIN) +20%Broadway Financial (BYFC) +18%.Amesite (AMST) +18%.Siebert Financial (SIEB) +16%.Losers: Recon Technolo...
Gainers: Novan (NOVN) +81%, Aptinyx (APTX) +25%, Vaxart (VXRT) +39%, Progenity (PROG) +28%, Chemomab Therapeutics (CMMB) +9%.Losers: Orphazyme (ORPH) -41%, Curis (CRIS) -32%, Aptose Biosciences (APTO) -30%, Galecto (GLTO) -22%,&...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biogen (NASDAQ: BIIB ) stock is dipping lower today on the additional controversy surrounding the approval of its Alzheimer’s drug, Aduhelm. Source: PictureDesignSwiss / Shutterstock.com Here’s e...
AndrewJohnson/E+ via Getty Images After over a fourfold rise value yesterday, Orphazyme ([[ORPH]] -44.3%) has lost more than a third so far in morning hours. Issuing a clarification, the company said that it was not aware of any reason that caused such extreme volatility in price and vol...
News, Short Squeeze, Breakout and More Instantly...
Orphazyme A/S Company Name:
ORPH Stock Symbol:
NASDAQ Market:
(NewsDirect) hVIVO PLC (AIM:HVO) chief executive Yamin 'Mo' Khan discusses the company's record-breaking financial results in 2023 in an interview with Proactive's Stephen Gunnion. hVIVO announced a 16% year-on-year growth in revenue, reaching £56 million, with an EBITDA margin i...
(NewsDirect) hVIVO chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions whil...
(NewsDirect) hVIVO PLC (AIM:HVO) Chief Scientific Officer Andrew Catchpole speaks to Steve Darling from Proactive after the specialist contract research organisation announced it has secured a £6.3 million contract with a biotechnology client for the testing of their antiviral candid...